Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
PBS (Phosphate-Buffered Saline) Workflow Guide
2026-09-29
PBS (Phosphate-Buffered Saline), SKU K2818, provides a sterile, ready-to-use isotonic buffer for cell washing, reagent dilution, and other in vitro workflows requiring controlled pH and osmolarity. It is intended for scientific research only and should not replace complete cell culture medium or be used for diagnostic, clinical, or medical purposes.
-
TaCRVP Hijacks Tomato Catalase to Suppress Defense
2026-09-29
A 2026 Advanced Science study identifies TaCRVP, a cysteine-rich venom protein in Tuta absoluta oral secretions, as an effector that redirects tomato redox regulation. By activating and stabilizing SlCAT2, TaCRVP suppresses hydrogen peroxide accumulation, downstream jasmonic acid signaling, and defensive metabolite production, revealing a mechanistic route by which a chewing herbivore manipulates host immunity.
-
Preserving Phosphosignals in Metabolic Research
2026-09-28
A translational framework for protecting phosphorylation-dependent readouts in liver metabolism studies, using the SREBP-1c–CSE/H2S–ULK1 axis as a mechanistic case study and Phosphatase Inhibitor Cocktail 3 as a practical preanalytical control.
-
ANGPTL3 sgRNA: A Multiplex Editing Strategy
2026-09-28
Explore how ANGPTL3 sgRNA targeting can support gene-function studies, and why a three-guide set is best treated as an experimental design opportunity rather than a guaranteed knockout. This guide connects multiplex CRISPR principles to practical decisions about editing, genotyping, and interpretation.
-
Carvacrol as a TRPA1 Probe in Redox Assays
2026-09-27
Carvacrol (5-isopropyl-2-methylphenol) offers a useful, non-electrophilic TRPA1 agonist perspective for interpreting redox-sensitive channel assays. This article explains how ligand-selective responses to singlet oxygen can sharpen experimental design without overstating what the evidence shows.
-
EZ Cap™ Cas9 mRNA (5-moUTP) for Fyn–Stat3 Studies
2026-09-26
Use EZ Cap™ Cas9 mRNA (5-moUTP) to build guide-directed loss-of-function tests around the Fyn–Stat3 neurodegeneration findings—without confusing gene editing with the study’s transgenic overexpression model. This workflow pairs careful RNA handling with dose, guide, and timing controls for interpretable functional gene studies.
-
QX77 and the Next Questions in Autophagy Research
2026-09-25
QX77 offers a way to investigate LAMP2A and Rab11 regulation in chaperone-mediated autophagy. In the context of recent ETS1–SENP2–HSPA8–FUNDC1 findings in bronchopulmonary dysplasia, this article outlines how translational researchers can connect distinct autophagy mechanisms without conflating them—and design more informative experiments.
-
Levofloxacin: Resistance Signals to Translational Design
2026-09-25
Levofloxacin connects bacterial DNA replication research with questions in bone and cartilage biology. This article interprets recent carbapenem-resistant Enterobacter cloacae findings alongside assay considerations, highlighting how to distinguish resistance associations from mechanism and how to design more informative translational studies.
-
CD28–ARS2 Splicing Reprograms CD8+ T-Cell Metabolism
2026-09-24
The study identifies a CD28–ARS2 signaling axis that changes alternative splicing in activated CD8+ T cells, favoring PKM2 over PKM1 and supporting glucose-use flexibility, IFN-γ production, and antitumor activity. Its findings connect costimulatory signaling to RNA processing independently of CD28-driven PI3K activation, giving researchers a distinct mechanism to test when studying T-cell function.
-
Cyanidin Chloride: From Redox Signal to Cell Phenotype
2026-09-24
Cyanidin Chloride is an anthocyanin polyphenolic antioxidant used to investigate redox biology, but radical-scavenging results alone do not establish cellular protection. This guide explains how to connect chemical identity, assay controls, and cell-level outcomes while interpreting a recent skin-model study with appropriate limits.
-
EZ Cap Cy5 Firefly Luciferase mRNA Assay Guide
2026-09-23
Separate mRNA-associated fluorescence from productive protein expression in one reporter workflow. This guide combines Cy5 tracking with luciferase readouts and uses cell-line and dose choices informed by recent mRNA-LNP assay findings.
-
Coumestrol in Ferroptosis and RA-FLS Research
2026-09-23
Coumestrol enables a research workflow that connects estrogen receptor signaling with mitochondrial stress, ferroptosis, and inflammatory behavior in rheumatoid arthritis fibroblast-like synoviocytes. Its receptor activity and formulation constraints also make it useful for carefully controlled selective estrogen receptor modulator (SERM) studies and nuclear receptor modulation experiments.
-
Baicalin Methyl Ester for Barrier Models
2026-09-22
Baicalin methyl ester supports a practical, multi-endpoint strategy for modeling inflammation-driven epithelial barrier failure. This guide connects solvent handling, MODE-K workflows, tight-junction analysis, cytokine profiling, and oral mouse studies while separating reported evidence from assay recommendations.
-
TAK-242: Precision Control of TLR4 Signaling
2026-09-22
TAK-242 (Resatorvid) gives translational researchers a selective pharmacological handle on TLR4 signaling. This article connects its LPS-response profile with the FXR/TLR4/ferroptosis findings reported in LX-2 cells, then outlines practical validation, cross-domain limitations, and a strategy for advancing TLR4 pathway studies toward more informative inflammation models.
-
Optimizing hiPSC Platelet Differentiation: Study Insights
2026-09-21
A 2026 study in Stem Cell Reviews and Reports optimized an embryoid-body-based workflow for producing megakaryocytes and functional platelets from human induced pluripotent stem cells. The protocol shortened differentiation to 19 days, reached 14.9 platelets per input iPSC, and reduced reported costs by 58.3%, while replacing selected cytokines with small molecules.